NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection

被引:153
|
作者
Draghi, Monia
Pashine, Achal
Sanjanwala, Bharati
Gendzekhadze, Ketevan
Cantoni, Claudia
Cosman, David
Moretta, Alessandro
Valiante, Nicholas M.
Parham, Peter
机构
[1] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA
[3] Novartis Corp, Novartis Vaccines & Diagnost, Oakland, CA 94608 USA
[4] Amgen Inc, Dept Oncol, Seattle, WA 98101 USA
[5] Univ Genoa, Dept Expt Med, Ist Giannina Gaslini, Genoa, Italy
来源
JOURNAL OF IMMUNOLOGY | 2007年 / 178卷 / 05期
关键词
D O I
10.4049/jimmunol.178.5.2688
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
At an early phase of viral infection, contact and cooperation between dendritic cells (DCs) and NK cells activates innate immunity, and also influences recruitment, when needed, of adaptive immunity. Influenza, an adaptable fast-evolving virus, annually causes acute, widespread infections that challenge the innate and adaptive immunity of humanity. In this study, we dissect and define the molecular mechanisms by which influenza-infected, human DCs activate resting, autologous NK cells. Three events in NK cell activation showed different requirements for soluble mediators made by infected DCs and for signals arising from contact with infected DCs. IFN-alpha was mainly responsible for enhanced NK cytolysis and also important for CD69 up-regulation, whereas IL-12 was necessary for enhancing IFN-gamma production. Increased CD69 expression and IFN-gamma production, but not increased cytolysis, required recognition of influenza-infected DCs by two NK cell receptors: NKG2D and NKp46. Abs specific for these receptors or their known ligands (UL16-binding proteins 1-3 class I-like molecules for NKG2D and influenza hemagglutinin for NKp46) inhibited CD69 expression and IFN-gamma production. Activation of NK cells by influenza-infected DCs and polyinosinic:polycytidylic acid (poly(I:C) -treated DCs was distinguished. Poly(I:C)-treated DCs did not express the UL16-binding protein 3 ligand for NKG2D, and in the absence of the influenza hemagglutinin there was no involvement of NKp46.
引用
收藏
页码:2688 / 2698
页数:11
相关论文
共 50 条
  • [1] Fantastic three: the role of CD16, NKG2D and Nkp46 as "master regulators'' of NK cell activation
    Imsirovic, Vanna
    Polic, Bojan
    Wensveen, Felix Martinus
    Jelencic, Vedrana
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 190 - 190
  • [2] Tumour-experienced T cells promote NK cell activity through trogocytosis of NKG2D and NKp46 ligands
    Domaica, Carolina I.
    Fuertes, Mercedes B.
    Rossi, Lucas E.
    Girart, Maria V.
    Avila, Damian E.
    Rabinovich, Gabriel A.
    Zwirner, Norberto W.
    EMBO REPORTS, 2009, 10 (08) : 908 - 915
  • [3] Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions
    Garcia-Iglesias, Trinidad
    del Toro-Arreola, Alicia
    Albarran-Somoza, Benibelks
    del Toro-Arreola, Susana
    Sanchez-Hernandez, Pedro E.
    Guadalupe Ramirez-Duenas, Maria
    Adriana Balderas-Pena, Luz Ma
    Bravo-Cuellar, Alejandro
    Ortiz-Lazareno, Pablo C.
    Daneri-Navarro, Adrian
    BMC CANCER, 2009, 9
  • [4] Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions
    Trinidad Garcia-Iglesias
    Alicia del Toro-Arreola
    Benibelks Albarran-Somoza
    Susana del Toro-Arreola
    Pedro E Sanchez-Hernandez
    Maria Guadalupe Ramirez-Dueñas
    Luz Ma. Adriana Balderas-Peña
    Alejandro Bravo-Cuellar
    Pablo C Ortiz-Lazareno
    Adrian Daneri-Navarro
    BMC Cancer, 9
  • [5] Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
    Ofer Mandelboim
    Niva Lieberman
    Marianna Lev
    Lada Paul
    Tal I. Arnon
    Yuri Bushkin
    Daniel M. Davis
    Jack L. Strominger
    Jonathan W. Yewdell
    Angel Porgador
    Nature, 2001, 409 : 1055 - 1060
  • [6] Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire
    Sheppard, Sam
    Triulzi, Chiara
    Ardolino, Michele
    Serna, Daniel
    Zhang, Lily
    Raulet, David H.
    Guerra, Nadia
    BLOOD, 2013, 121 (25) : 5025 - 5033
  • [7] Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
    Mandelboim, O
    Lieberman, N
    Lev, M
    Paul, L
    Arnon, TI
    Bushkin, Y
    Davis, DM
    Strominger, JL
    Yewdell, JW
    Porgador, A
    NATURE, 2001, 409 (6823) : 1055 - 1060
  • [8] Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
    Han, Bin
    Mao, Fang-yuan
    Zhao, Yong-liang
    Lv, Yi-pin
    Teng, Yong-sheng
    Duan, Mubing
    Chen, Weisan
    Cheng, Ping
    Wang, Ting-ting
    Liang, Zhong-yuan
    Zhang, Jin-yu
    Liu, Yu-gang
    Guo, Gang
    Zou, Quan-ming
    Zhuang, Yuan
    Peng, Liu-sheng
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [9] LIVER TRANSPLANTATION (LT) RESULTS IN REDUCED RECIPIENT NATURAL KILLER (NK) CELL ACTIVATION WITH ASSOCIATED DOWN REGULATION OF ACTIVATING RECEPTORS NKP30 AND NKP46 BUT NOT NKG2D
    Jamil, Khaleel
    Cheent, Kudeep S.
    Agarwal, Kosh
    Alexander, Graeme J.
    Heneghan, Michael A.
    Khakoo, Salim
    HEPATOLOGY, 2011, 54 : 1101A - 1101A
  • [10] Recognition and Killing of Human and Murine Pancreatic β Cells by the NK Receptor NKp46
    Gur, Chamutal
    Enk, Jonatan
    Kassem, Sameer A.
    Suissa, Yaron
    Magenheim, Judith
    Stolovich-Rain, Miri
    Nir, Tomer
    Achdout, Hagit
    Glaser, Benjamin
    Shapiro, James
    Naparstek, Yaakov
    Porgador, Angel
    Dor, Yuval
    Mandelboim, Ofer
    JOURNAL OF IMMUNOLOGY, 2011, 187 (06): : 3096 - 3103